You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTGX Sale Disclosure
Waddill William D. · SEC Form 4 · Filed Jun 11, 2026
Sale
Calculated transaction value
$969.12K
Waddill William D. Director
PTGX
Transaction date
Jun 10, 2026
Public filing date
Jun 11, 2026
Filing lag
Filed 1 day later
PTGX daily price context
Close on/before transaction
$105.77
Jun 10, 2026
First close after public filing
$109.78
Jun 12, 2026
30-day return after filing
+18.32%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,000 shares @ $107.68
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001104659-26-073049
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$1.1M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protagonist Therapeutics, Inc PTGX | Exercise | Jun 10, 2026 | $35.4K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Jun 10, 2026 | $99.24K |
| Protagonist Therapeutics, Inc PTGX Current | Sale | Jun 10, 2026 | $969.12K |
| Protagonist Therapeutics, Inc PTGX | Exercise | Jun 10, 2026 | $0 |
| Protagonist Therapeutics, Inc PTGX | Exercise | Jun 10, 2026 | $0 |